Skip to content
10-Q

Quarterly Report

HELIX BIOMEDIX INC

0001437749-11-008008

← back to feed
Filed
Nov 3, 2011 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2011 · Oct 31, 2011 49.72M sh
Stockholders Equity Q3 2011 · Sep 30, 2011 $3.07M
Stockholders Equity Q3 2011 · Dec 31, 2009 −$5.17M
Current Liabilities Q3 2011 · Sep 30, 2011 $334.69K
Current Liabilities Q3 2011 · Dec 31, 2010 $318.22K
Total Liabilities Q3 2011 · Sep 30, 2011 $365.29K
Total Liabilities Q3 2011 · Dec 31, 2010 $354.04K
Current Assets Q3 2011 · Sep 30, 2011 $2.98M
Current Assets Q3 2011 · Dec 31, 2010 $4.67M
Total Assets Q3 2011 · Sep 30, 2011 $3.43M
Total Assets Q3 2011 · Dec 31, 2010 $5.23M
Net Income Q3 2011 · Sep 30, 2011 −$1.94M
Net Income Q3 2011 · Dec 31, 2010 −$7.71M
Net Income Q3 2011 · Sep 30, 2010 −$1.12M
Net Income Q3 2011 · Sep 30, 2010 −$2.99M
Shares Diluted Q3 2011 · Sep 30, 2010 25.65M sh
Shares Diluted Q3 2011 · Sep 30, 2010 25.65M sh
Capex Q3 2011 · Sep 30, 2010 $2.55K
Operating Cash Flow Q3 2011 · Sep 30, 2010 −$2.16M
Cash And Equivalents Q3 2011 · Sep 30, 2010 $2.03M
Cash And Equivalents Q3 2011 · Dec 31, 2009 $1.34M
Eps Diluted Q3 2011 · Sep 30, 2010 −$0.04
Eps Diluted Q3 2011 · Sep 30, 2010 −$0.12
Sga Expense Q3 2011 · Sep 30, 2010 $431.2K
Sga Expense Q3 2011 · Sep 30, 2010 $1.14M
Rd Expense Q3 2011 · Sep 30, 2010 $196.75K
Rd Expense Q3 2011 · Sep 30, 2010 $572.62K
Operating Income Q3 2011 · Sep 30, 2010 −$892.03K
Operating Income Q3 2011 · Sep 30, 2010 −$2.38M
Gross Profit Q3 2011 · Sep 30, 2010 $64.64K
Gross Profit Q3 2011 · Sep 30, 2010 $315.53K
Cost Of Revenue Q3 2011 · Sep 30, 2010 $29.04K
Cost Of Revenue Q3 2011 · Sep 30, 2010 $178.27K
Revenue Q3 2011 · Sep 30, 2010 $93.68K
Revenue Q3 2011 · Sep 30, 2010 $493.8K